Analytical Data
-
Gene name
MGC50559
- Application
-
Alternative Names
Electron transfer flavoprotein subunit beta lysine methyltransferase
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
G5EA40
-
Expression Region
1-262 aa
-
AA Sequence
MALSLGWKAHRNHCGLLLQALRSSGLLLFPCGQCPWRGAGSFLDPEIKAFLEENTEVTSSGSLTPEIQLRLLTPRCKFWWERADLWPHSDPYWAIYWPGGQALSRYLLDNPDVVRGKSVLDLGSGCGATAIAAKMSGASRILANDIDPIAGMAITLNCELNRLNPFPILIQNILNLEQDKWDLVVLGDMFYDEDLADSLHQWLKKCFWTYRTRVLIGDPGRPQFSGHSIQHHLHKVVEYSLLESTRQENSGLTTSTVWGFQP
-
Molecular Weight
55.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MGC50559 is a recombinant protein that has garnered attention in the field of biochemistry and molecular biology due to its potential applications in therapeutic development and protein engineering. This protein is derived from the gene sequence identified in a specific organism, which was selected for its unique structural and functional properties. Research into MGC50559 focuses on its role in cellular pathways and interactions, providing insights into disease mechanisms, particularly in cancer and metabolic disorders. The ability to produce MGC50559 in a lab setting using recombinant DNA technology allows for detailed studies on its biochemical properties, including its stability, activity, and potential as a drug target or biomarker. Furthermore, MGC50559's expression profile can illuminate its relevance in various tissues and conditions, paving the way for new diagnostic and therapeutic strategies. As a model protein, MGC50559 represents a valuable tool for understanding protein function and interaction, driving forward the fields of personalized medicine and biotechnology. The ongoing research aims to delve deeper into its mechanisms of action, facilitating the innovation of novel therapeutic approaches that leverage the unique characteristics of this recombinant protein.
